Neurotrophic Keratopathy Treated with Topical Recombinant Human Nerve Growth Factor (Cenegermin): Case Series Study with Long-Term Follow-Up.

Autor: García-Delpech, Salvador1 (AUTHOR), Udaondo, Patricia1 (AUTHOR), Fernández-Santodomingo, Alex Samir1 (AUTHOR), García-Teillard, Damian2 (AUTHOR)
Zdroj: Case Reports in Ophthalmology. 2022, Vol. 13 Issue 2, p663-670. 8p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje